Management of Post-Traumatic Stress Disorder (PTSD)

Pharmacological Interventions

The American Academy of Sleep Medicine strongly recommends prazosin as the first-line pharmacological treatment for PTSD-associated flashbacks and nightmares, with a starting dose of 1 mg at bedtime, gradually increasing by 1-2 mg every few days until effective, and an average effective dose of 3 mg (range 1-10+ mg), with higher doses (9.5-13.3 mg/day) potentially needed in more severe cases, while monitoring for orthostatic hypotension (Level A evidence) 1
Clonidine may be considered for PTSD-associated flashbacks, with a dose range of 0.2-0.6 mg daily (in divided doses), as an α2-adrenergic receptor agonist that suppresses sympathetic nervous system outflow, can reduce startle reactions, and may decrease flashback frequency, while monitoring for blood pressure changes and potential falls (Level C evidence) 2, 1

Image Rehearsal Therapy is effective for reducing flashbacks and nightmares, involving rescripting traumatic memories into less distressing narratives, and practicing daily for optimal results 1
Sensory Grounding Techniques can help keep patients present in the moment, focusing on environmental details, cognitive distractions, and sensory-based distractors, and are recommended for acute management of flashbacks 3
Establishing daily plans and structure can help prevent cognitive overload, and regular follow-up every 2-3 months is essential to assess treatment effectiveness using symptom tracking 3

Sensory grounding techniques should be employed immediately during an active flashback 3
Restrictive interventions should be avoided as punishment or for convenience, and psychological debriefing should not be used for recent traumatic events as it may increase the risk of PTSD symptoms 4, 5
Clinicians should be aware of the potential for misdiagnosis, overmedication, and neglecting comorbidities, such as depression, anxiety, and substance use disorders, which frequently co-occur with PTSD and require concurrent management 5